In ST-elevation myocardial infarction (STEMI) patients with diffuse ectatic coronary artery, extensive thrombi inhibit achievement of final successful revascularization of Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow after primary percutaneous coronary intervention. However, clinical and angiographic outcomes of such patients are uncertain. The present study examined clinical and angiographic outcomes in STEMI incorporating giant coronary artery with diffuse ectasia.
Methods:
Seven hundred and forty-four STEMI patients undergoing primary percutaneous coronary intervention were surveyed retrospectively. Culprit lesions in giant coronary artery with diffuse ectasia (Ectatic group, n=39) were investigated. Percutaneous coronary intervention success rate and angiographic or clinical outcomes at 360 days were compared with those of the Non-ectatic group (n=705).
Results:
Angiographic percutaneous coronary intervention success rate was significantly lower in the Ectatic group due to lower achievement of final TIMI grade 3 flow (53.8% vs. 92.9%, p<0.0001; 53.8% vs. 93.5%, p<0.0001, respectively). In follow-up angiography, 86% of the Ectatic group showed angiographic improvement from TIMI grade 2 or less immediately after percutaneous coronary intervention to TIMI grade 3 flow at follow-up. In contrast, angiographic improvement was observed in only 25% of cases in the Non-ectatic group. All-cause 360-day mortality was significantly lower in the ectatic group (2.6% vs. 14.5%, p=0.0361, respectively).
Conclusion:
In patients with STEMI in giant coronary artery with diffuse ectasia, achievement of TIMI grade 3 flow was significantly reduced immediately after percutaneous coronary intervention. However, improvement of coronary flow up to TIMI grade 3 was not uncommon at follow-up angiogram. Patients had low mortality despite low TIMI grade 3 achievement immediately after primary percutaneous coronary intervention.
DangasGDCaixetaAMehranR.; Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation2011; 123: 1745–1756.
2.
van WerkumJWHeestermansAAZomerAC. Predictors of coronary stent thrombosis: The Dutch Stent Thrombosis Registry. J Am Coll Cardiol2009; 53: 1399–1409.
3.
StegPGvan ’t HofAHammCW.; for the EUROMAX Investigators. Bivalirudin started during emergency transport for primary PCI. N Engl J Med2013; 369: 2207–2217.
4.
MrdovicIJozicTAsaninM. Myocardial reinfarction in a patient with coronary ectasia. Cardiology2004; 102: 32–4.
5.
TanabeYItohENakagawaI. Pulse-spray thrombolysis in acute myocardial infarction caused by thrombotic occlusion of an ectatic coronary artery. Circ J2002; 66: 207–210.
6.
KuhlMVarmaC. A case of acute coronary thrombosis in diffuse coronary artery ectasia. J Invasive Cardiol2008; 20: E23–E25.
7.
FurugenMTakagawaY. Staged interventional management of a massive thrombus related to coronary artery ectasia in acute coronary syndrome. Cardiovasc Interv Ther2012; 27: 57–61.
8.
YokokawaTUjiieYKanekoH. Lone aspiration thrombectomy without stenting for a patient with ST-segment elevation myocardial infarction associated with coronary ectasia. Cardiovasc Interv Ther2014; 29: 339–343.
9.
KammlerJKyptaAHofmannR. TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol2009; 98: 165–170.
10.
MarkisJEJoffeCDCohnPF. Clinical significance of coronary arterial ectasia. Am J Cardiol1976; 37: 217–222.
11.
ThygesenKAlpertJSJaffeAS. Third universal definition of myocardial infarction. Circulation2012; 126: 2020–2035.
12.
LevineGNBatesERBlankenshipJC. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol2011; 58: e44–e122.
13.
ChesebroJHKnatterudGRobertsR. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation1987; 76: 142–154.
14.
van ’t HofAWLiemASuryapranataH. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation1998; 97: 2302–2306.
15.
RyanTJFaxonDPGunnarRM. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation1988; 78: 486–502.
16.
EllisSGVandormaelMGCowleyMJ. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation1990; 82: 1193–1202.
17.
HuberMSMooneyJFMadisonJ. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol1991; 68: 467–471.
RobertsonTFisherL. Prognostic significance of coronary artery aneurysm and ectasia in the Coronary Artery Surgery Study (CASS) registry. Prog Clin Biol Res1987; 250: 325–339.
20.
MavrogeniS. Coronary artery ectasia: From diagnosis to treatment. Hellenic J Cardiol2010; 51: 158–163.
LamCSHoKT. Coronary artery ectasia: A ten-year experience in a tertiary hospital in Singapore. Ann Acad Med Singapore2004; 33: 419–422.
23.
Ruiz-MoralesJMGonzalez-ChonOGarcia-LopezSMC. Coronary artery ectasia prevalence and clinical characteristics: Experience from a single medical center. Rev Invest Med Sur Mex2013; 20: 208–213.
24.
BolesURakhitRShiuMF. Coronary artery ectasia as a culprit for acute myocardial infarction: Review of pathophysiology and management. Anadolu Kardiyol Derg2013; 13: 695–701.
25.
DemopoulosVPOlympiosCDFakiolasCN. The natural history of aneurysmal coronary artery disease. Heart1997; 78: 136–141.
26.
YipHKChenMCWuCJ. Clinical features and outcome of coronary artery aneurysm in patients with acute myocardial infarction undergoing a primary percutaneous coronary intervention. Cardiology2002; 98: 132–140.
27.
BrenerSJBarrLABurchenalJE. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation1998; 98: 734–741.
28.
MehtaRHBatesER. Coronary stent implantation in acute myocardial infarction. Am Heart J1999; 137: 603–611.
29.
MontalescotGBarraganPWittenbergO. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med2001; 344: 1895–1903.
30.
MehtaRHHarjaiKJCoxD.; Primary Angioplasty in Myocardial Infarction Investigators. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol2003; 42: 1739–1746.
31.
KennerMDZajacEJKondosGT. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol1995; 76: 861–868.
32.
ItoHMaruyamaAIwakuraK. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation1996; 93: 223–228.
33.
GiriSMitchelJFHirstJA. Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction. Am J Cardiol2000; 86: 269–274.
34.
StoneGWWebbJCoxDA. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A randomized controlled trial. JAMA2005; 293: 1063–1072.
35.
FujiiTMasudaNNakanoM. Impact of transient or persistent slow flow and adjunctive distal protection on mortality in ST-segment elevation myocardial infarction. Cardiovasc Interv Ther2015; 30: 121–130.
36.
VichovaTMalyMUlmanJ. Mortality in patients with TIMI 3 flow after PCI in relation to time delay to reperfusion. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. Epub ahead of print 27April2015. DOI: 10.5507/bp.2015.015.
37.
MehtaRHHarjaiKJBouraJ.; Primary Angioplasty in Myocardial Infarction Investigators. Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol2003; 92: 1445–1447.
38.
NiccoliGLanzaGAShawS. Endothelin-1 and acute myocardial infarction: A no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J2006; 27: 1793–1798.
39.
NiccoliGLanzaGASpazianiC. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction. Int J Cardiol2007; 117: 306–311.
40.
NiccoliGGiubilatoSRussoE. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J2008; 29: 1843–1850.
